0001209191-19-039109.txt : 20190626
0001209191-19-039109.hdr.sgml : 20190626
20190626163548
ACCESSION NUMBER: 0001209191-19-039109
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190624
FILED AS OF DATE: 20190626
DATE AS OF CHANGE: 20190626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Knickerbocker Aron Marc
CENTRAL INDEX KEY: 0001578766
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36070
FILM NUMBER: 19922075
MAIL ADDRESS:
STREET 1: C/O FIVE PRIME THERAPEUTICS, INC.
STREET 2: TWO CORPORATE DRIVE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC
CENTRAL INDEX KEY: 0001175505
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 260038620
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-365-5600
MAIL ADDRESS:
STREET 1: 111 OYSTER POINT BOULEVARD
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-24
0
0001175505
FIVE PRIME THERAPEUTICS INC
FPRX
0001578766
Knickerbocker Aron Marc
111 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President & CEO
Performance-Based Restricted Common Stock
2019-06-24
4
A
0
124420
0.00
A
Common Stock
124420
124420
D
These shares will vest upon achievement of certain performance conditions, as further described in Footnote 2.
(i) 50% of the shares subject to this award will vest on the date that
the 30-calendar-day volume-weighted average closing price of a share of common stock of Five Prime Therapeutics, Inc. (the "Company") is greater than or equal to $12.95, provided that such shares shall automatically expire and be forfeited if such shares have not vested by December 31, 2020; and (ii) 50% of the shares subject to this award will vest on the date that the 30-calendar-day volume-weighted average closing price of a share of common stock of the Company is greater than or equal to $19.43, provided that such shares shall automatically expire and be forfeited if such shares have not vested by December 31, 2021; in each case, subject to the reporting person's continued service to the Company through each such date.
/s/ Francis Sarena, Attorney-in-fact
2019-06-26